This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Nov;24(6):678-94.

doi: 10.1007/BF03006711.

The caffeine test of isolated human muscle in relation to malignant hyperthermia

W Kalow, B A Britt, A Richter

PMID: 589505
DOI: 10.1007/BF03006711

The caffeine test of isolated human muscle in relation to malignant hyperthermia

W Kalow et al. Can Anaesth Soc J. 1977 Nov.

. 1977 Nov;24(6):678-94.

doi: 10.1007/BF03006711.

Authors

W Kalow, B A Britt, A Richter

PMID: 589505
DOI: 10.1007/BF03006711

No abstract available

PubMed Disclaimer

Similar articles

A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
Halsall PJ, Ellis FR. Halsall PJ, et al. Br J Anaesth. 1979 Aug;51(8):753-6. doi: 10.1093/bja/51.8.753. Br J Anaesth. 1979. PMID: 497072
[Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
Urwyler A, Censier K, Seeberger MD, Drewe J, Rothenbühler JM, Frei F. Urwyler A, et al. Schweiz Med Wochenschr. 1991 Apr 20;121(16):566-71. Schweiz Med Wochenschr. 1991. PMID: 2042040 German.
Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
Takagi A, Sunohara N, Ishihara T, Nonaka I, Sugita H. Takagi A, et al. Muscle Nerve. 1983 Sep;6(7):510-4. doi: 10.1002/mus.880060707. Muscle Nerve. 1983. PMID: 6633564
[Malignant hyperthermia].
Glahn KP. Glahn KP. Ugeskr Laeger. 2003 Apr 21;165(17):1763-8. Ugeskr Laeger. 2003. PMID: 12768904 Review. Danish.
Diagnosis of susceptibility to malignant hyperthermia in man.
Ording H. Ording H. Br J Anaesth. 1988 Feb;60(3):287-302. doi: 10.1093/bja/60.3.287. Br J Anaesth. 1988. PMID: 3279989 Review. No abstract available.

See all similar articles

Cited by

Anesthesia in 1984: how safe is it?
Davies JM, Strunin L. Davies JM, et al. Can Med Assoc J. 1984 Sep 1;131(5):437-41. Can Med Assoc J. 1984. PMID: 6467115 Free PMC article.
Effects of anesthetic and related agents on calcium-induced calcium release from sarcoplasmic reticulum isolated from rabbit skeletal muscle.
Wakamatsu M, Yamamoto M, Kirino Y, Katoh H, Shimonaka H, Nozawa Y. Wakamatsu M, et al. J Anesth. 1989 Mar 1;3(1):1-9. doi: 10.1007/s0054090030001. J Anesth. 1989. PMID: 15236048
Membrane abnormality in malignant hyperthermia.
Shah A, Sahgal V, Subramani V. Shah A, et al. Acta Neuropathol. 1989;78(1):86-9. doi: 10.1007/BF00687406. Acta Neuropathol. 1989. PMID: 2735191
Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
Adnet PJ, Krivosic-Horber RM, Haudecoeur G, Reyford HG, Adamantidis MM, Dupuis BA. Adnet PJ, et al. Can J Anaesth. 1990 Jul;37(5):556-9. doi: 10.1007/BF03006325. Can J Anaesth. 1990. PMID: 2372858
Association of post-anaesthetic hyperthermia with abnormal muscle characteristics: a case report.
Kripke BJ, Blanck TJ, Sizemore DA, Comunale FL, Christiansen J, Gruener R. Kripke BJ, et al. Can Anaesth Soc J. 1983 May;30(3 Pt 1):290-4. doi: 10.1007/BF03013810. Can Anaesth Soc J. 1983. PMID: 6336551

See all "Cited by" articles

References

1. Can Anaesth Soc J. 1969 Mar;16(2):89-98 - PubMed
1. Br J Anaesth. 1971 Aug;43(8):811-3 - PubMed
1. Exp Neurol. 1971 Feb;30(2):277-90 - PubMed
1. Fed Proc. 1972 Jul-Aug;31(4):1270-5 - PubMed
1. Ann Chir Gynaecol Fenn. 1974;63(3):212-6 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions